Connect with us

Hi, what are you looking for?

Stock

Australia’s CSL reaffirms commitment to making AstraZeneca COVID vaccine

Stock Markets55 minutes ago (Oct 13, 2021 08:16PM ET)

(C) Reuters. FILE PHOTO: Vials labelled “Astra Zeneca COVID-19 Coronavirus Vaccine” and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/File Photo

(Reuters) – Australian biotech CSL (OTC:CSLLY) said on Thursday it was committed to its agreement for the production of about 50 million doses of AstraZeneca (NASDAQ:AZN)’s COVID-19 vaccine into 2022.

The announcement came after a media report said the British drugmaker’s vaccine, Vaxzevria, will no longer be manufactured in Australia due to demand for vaccines of Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA). [nL4N2R91XR]

Pfizer and Moderna have established a market dominance by using mRNA-based COVID-19 vaccine technology to fight the pandemic.

CSL, in a brief statement, added that more than 20 million of the doses have already been produced, and it is expected that the remaining production will be completed early next year.

Cafes, gyms and restaurants in Sydney welcomed back fully vaccinated customers earlier this week after nearly four months of a lockdown, as Australia aims to begin living with the coronavirus and gradually reopen with high rates of inoculation.

Australia’s CSL reaffirms commitment to making AstraZeneca COVID vaccine

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BEST PICKS FOR YOU

I’m going to let you in on a little secret. I got a $750 SHEIN gift card this week and all I had to...

Stock

(C) Reuters. FILE PHOTO: A worker holds a nozzle to pump petrol into a vehicle at a fuel station in Mumbai, India, May 21,...

Sport

Reviewed by Helen Kollias, PhD What is adrenal fatigue? | Symptoms | Science | Treatment Every month, roughly 80,000 people type “what is adrenal...

Disclaimer: Wisegazette.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved